Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide Chemotherapy

NCT04937309 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT04937309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide Chemotherapy
Lead sponsor
University Hospital, Tours
Phase
Not applicable
Overall status
Recruiting
Start date
June 23, 2022
Completion date
September 30, 2028
Enrollment
338 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer